ERP for Pharma Wholesale — software for Pharma-Wholesale under AMG, GDP and securPharm

Pharmaceutical wholesale (Pharma-Großhandel) is one of the most heavily regulated wholesale verticals in the DACH region. An ERP for pharma wholesale has to satisfy the German Medicinal Products Act (AMG, Arzneimittelgesetz), Good Distribution Practice (GDP) requirements, securPharm-based serialisation verification, narcotics (Betäubungsmittel, BtM) controls and validated cold-chain logistics — while serving an exclusively B2B customer base of pharmacies, hospitals and veterinary practices.

Requirements for pharma-wholesale ERP

The core requirement is verifiable compliance, not just operational efficiency. The ERP must maintain a validated state under GAMP 5 / GDP, with computer-system validation (CSV) documentation for every release. Batch genealogy is mandatory: every incoming pack must be traceable to its securPharm-verified unique identifier, every outgoing pack to the specific pharmacy or hospital that received it. Narcotics (BtM) flows need separate documentation, segregated storage and tamper-evident handling, with electronic BtM ledgers acceptable to the BfArM. Cold-chain products (vaccines, biologics, insulin) require validated 2–8°C handling with continuous temperature logging treated as quality data, not just operational data.

Mandatory functions

Non-negotiable functions include: securPharm verification at goods-in and at dispense (decommissioning); narcotics ledger with role-based access and the four-eyes principle on critical actions; validated cold-chain monitoring with deviation handling; batch and lot tracking through every pick and split; GDP-conformant supplier and customer qualification workflows; recall execution within the 24-hour window expected by BfArM/PEI; integration with pharmacy ordering protocols (e.g. MSV3) and hospital procurement portals; and a complete audit trail on all data changes for inspections by regional authorities and EU GDP auditors. Validation documentation (IQ/OQ/PQ) must be vendor-provided rather than reconstructed by the customer.

Typical Mid-Market profiles and real-world use cases

The German pharma-wholesale market is dominated at the top by four full-line distributors, but the mid-market is much more fragmented than is sometimes assumed. Three SME archetypes drive the bulk of mid-market ERP selection projects.

Profile 1 — the regional short-line distributor. A regional pharmaceutical short-line distributor in Bavaria with 110 employees, EUR 65 million in turnover, supplying 600–800 community pharmacies with the high-rotation OTC and Rx range, on a one-or-two-deliveries-per-day cycle. Pain point one is securPharm throughput at goods-in: 25,000–40,000 pack verifications per day against the NGDA hub, where any latency in the verification call translates directly into delayed shipments. Pain point two is the MSV3 order interface to pharmacy management systems — the standard order protocol that the entire community-pharmacy customer base uses. Any deviation from the MSV3 message schema generates support calls that the back office cannot afford. Pain point three is the very tight Rx delivery SLA: the regional Apothekenkammer expectation is two scheduled deliveries per working day plus emergency runs, which forces the warehouse and route-planning modules to operate at near-real-time cadence.

Profile 2 — the hospital-supply specialist. A 65-employee hospital-supply wholesaler in Hesse, EUR 140 million turnover (driven by oncology and biologics that carry high unit prices), supplying 35–50 hospitals across multiple Bundesländer. Pain point one is validated cold chain: a meaningful share of revenue ships at 2–8°C with continuous temperature logging treated as quality data, not just operational data. Deviation handling has to be GDP-conformant with documented investigation and disposition. Pain point two is hospital procurement portals: each hospital group runs a different e-procurement system (KMS, hospitalONE, GHX), and the ERP must translate the internal order back-end to each portal's master-data and pricing rules. Pain point three is BtM handling for opioid analgesics, which carries the four-eyes principle and a separate audit log accepted by the BfArM.

Profile 3 — the veterinary-pharma distributor. A 40-employee veterinary-pharmaceutical wholesaler in North Rhine-Westphalia, EUR 22 million turnover, supplying veterinary practices and clinics with prescription veterinary medicines, vaccines and feed additives. Pain point one is the new Animal Medicinal Products Act (TAMG) reporting under the German Tierärztliche Hausapothekenverordnung, which requires structured reporting of antibiotic usage by livestock species and indication. Pain point two is integration with the HIT livestock-traceability registry (the German origin-assurance and information system for animals), which the ERP has to feed with structured dispensing data. Compliance burden per employee is high because veterinary pharma carries both human-grade GDP obligations and species-specific reporting on top.

Vendor landscape

The German pharma-wholesale market is dominated by full-line distributors that mostly run in-house or heavily customised stacks — PHOENIX group, NOWEDA, GEHE and Sanacorp each operate proprietary or deeply tailored core systems. For mid-sized and specialist wholesalers (e.g. veterinary distribution, hospital supply, regional players), the credible vendor set includes Greco-Software, VENNESLAND Apotheker IT, NovaTec Pharma, NextPharma, NGDA Plus, GUS-OS Pharma, SAP IS-Wholesale (legacy) or S/4HANA with pharma add-ons, and specialist providers such as Inform or PROLOG with pharma-focused logistics modules. Microsoft Dynamics 365 Business Central with a certified pharma extension is occasionally found at the smaller end — the audit-trail mode has to be switched on and the validation kit has to come from the extension vendor, not be reconstructed by the customer. Validation effort and the depth of pre-built GDP/AMG content are the most decisive selection criteria.

Selection criteria for pharma wholesalers

• Native securPharm interface with NGDA hub connection, including retry and exception handling
• GDP-audit-grade audit trail with user, timestamp, before-value and after-value on every regulated transaction
• FIFO/FEFO picking with expiry-date priority and short-shelf-life alerts
• BtM (narcotics) module with segregated stock, four-eyes principle and BfArM-conformant ledger
• Validated cold-chain monitoring with IoT-sensor integration and CAPA workflow on deviations
• MSV3 pharmacy ordering interface plus hospital procurement-portal connectors (KMS, hospitalONE, GHX)
• GxP validation kit (IQ/OQ/PQ) maintained by the vendor with documented release-management
• Batch traceability across goods-in, picking, split shipments and recall
• Recall execution within the 24-hour BfArM/PEI window with structured customer notification
• 21 CFR Part 11 / EU Annex 11-aligned electronic-signature and record-keeping

Trends and outlook

Three developments are shaping pharma-wholesale ERP roadmaps. First, the EU's Falsified Medicines Directive (FMD) and the German implementation via securPharm are expanding into more product categories, raising the volume of verification transactions. Second, hospital direct-supply models and home-care logistics push wholesalers into temperature-validated last-mile delivery, which demands tighter ERP integration with telematics. Third, e-prescription (E-Rezept) rollouts in Germany change order patterns at the pharmacy level, indirectly increasing the cadence and granularity of wholesale orders — legacy nightly batch processing is no longer acceptable. A fourth trend, increasingly visible from 2025, is the upcoming EU IRIS data submissions and the broader EU Health Data Space, which will force structured master-data discipline on wholesalers that previously got by with informal product hierarchies.

Related Topics

• ERP for wholesale
• GUS-OS
• Microsoft Dynamics 365 Business Central
• Audit trail
• GxP validation
• Batch traceability
• GDP
• ERP consultants